PRGO · NYSE
Perrigo Company plc
$15.92 0.00 (0.00%)
Company overview
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand self-care products in categories including upper respiratory, pain and sleep aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NYSE
- Market cap
- $2.2B
- Employees
- 8,379
- Headquarters
- Dublin
- Website
- perrigo.com
- CEO
- Patrick Lockwood-Taylor
- Listed
- December 17, 1991
- P/E
- -1.21
- Dividend yield
- 8.01%
Company financials
- Revenue
- $4.2B
- Gross profit
- $1.4B
- Operating income
- $237M
- EBITDA
- -$838M
- Net income
- -$1.8B
- EPS
- -$13.11
- Total assets
- $8B
- Total debt
- $3.8B
- Gross margin
- 34.17%
- Net margin
- -43.50%
- Earnings yield
- -82.43%
Showing FY 2025
PRGO
1D
NYSE
O15.96H16.05L15.68C15.92-0.10 (-0.62%)Vol1.71M